Genique Lifesciences

India channel partner for AVITI + NGS stack. Platforms, panels, bioinformatics, counsellor-reviewed reports. SOPHiA Genetics APAC Distributor of the Year 24-25

[Genique Lifesciences @GeniqueLS]

One partner across the whole genomics workflow.
We bring sequencing platforms, panels and software to Indian labs — then stay for implementation, bioinformatics and counsellor-reviewed reports. Global technology. Local stack. No orphaned instrument.
1/7

[Genique Lifesciences @GeniqueLS]

Genique is at the Next Gene Biosciences Summit 2026 @themastersunion #NextGene

[Genique Lifesciences @GeniqueLS]

Website: https://t.co/2KGOZH2NmR
Phone: [phone]
Office: Unit-805, Unitech Arcadia, South City-2, Sector 49, Gurugram

[Genique Lifesciences @GeniqueLS]

One partner across the whole genomics workflow.
We bring sequencing platforms, panels and software to Indian labs — then stay for implementation, bioinformatics and counsellor-reviewed reports. Global technology. Local stack. No orphaned instrument.
1/7

[Genique Lifesciences @GeniqueLS]

Tell us about your lab and where you want to take it.
We’ll match the platform, chemistry and support to the answers you need.
Email [email protected]
Ask for an introduction meeting.

[Genique Lifesciences @GeniqueLS]

Where this is already running.
Founded in Gurugram, 2018.
22 institutions served.
People on the ground in 6 cities: Gurugram, Delhi, Mumbai, Chennai, Bengaluru, Hyderabad.
@SOPHiAGENETICS APAC Distributor of the Year — 2024 and 2025.
6/7

[Genique Lifesciences @GeniqueLS]

Rapid whole genome sequencing in the NICU is usually argued down on three grounds: too slow, too expensive, better held in reserve until other testing is exhausted.

Project Baby Bear sequenced 184 critically ill infants across five California ICUs. 74 received a diagnosis, in a median of 3 days. Care changed for 58 of the 184 infants tested. Testing cost $1.7 million and was associated with $2.2 to $2.9 million in reduced hospital costs, most of it from shorter admissions (Dimmock et al., Am J Hum Genet 2021).

The same paper modelled what would have happened at a slower turnaround. At 7 days the savings fell by roughly a fifth. At 14 days they roughly halved.

So the three objections are not independent. Held in reserve, the test arrives late, and arriving late is what makes it expensive.

Genique Lifesciences distributes @ElemBio Element Biosciences sequencing systems in India. Element reports whole genome sequencing of one or two human trios in 38 hours on the AVITI™ System using Cloudbreak™ chemistry.

#NeonatalGenomics #GenomicMedicine

[Genique Lifesciences @GeniqueLS]

𝗚𝗲𝗻𝗶𝗾𝘂𝗲 𝗟𝗶𝗳𝗲𝘀𝗰𝗶𝗲𝗻𝗰𝗲𝘀 × 𝗔𝘁𝗿𝗮𝗻𝗱𝗶 𝗕𝗶𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲𝘀
We’re excited to announce our collaboration with @AtrandiBio Atrandi Biosciences, bringing advanced single-cell and multi-omics technologies to researchers and laboratories across India.

Atrandi’s 𝗦𝗲𝗺𝗶-𝗣𝗲𝗿𝗺𝗲𝗮𝗯𝗹𝗲 𝗖𝗮𝗽𝘀𝘂𝗹𝗲 (𝗦𝗣𝗖) 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 enables scalable, multi-step workflows while maintaining single-cell resolution, giving researchers new ways to investigate complex biological systems across genomics, cancer research, microbiology, and life sciences.

Through this collaboration, researchers can explore:
• High-throughput single-cell analysis
• Flexible multi-omic workflows at single-cell resolution
• Single-cell DNA and RNA co-sequencing
• Single-cell microbial genomics

Our goal is to make advanced single-cell and multi-omics workflows more accessible to the Indian research community and support laboratories in exploring biology with greater depth and precision.

We’re proud to partner with Atrandi Biosciences and look forward to supporting researchers as they push the boundaries of what’s possible in single-cell research.

𝗠𝗼𝗿𝗲 𝗽𝗼𝘀𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀. 𝗚𝗿𝗲𝗮𝘁𝗲𝗿 𝗿𝗲𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻. 𝗗𝗲𝗲𝗽𝗲𝗿 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀.

https://t.co/4swCj5GweI

#GeniqueLifesciences #AtrandiBiosciences #SingleCell #MultiOmics #Genomics

[Genique Lifesciences @GeniqueLS]

Precision in Practice: Genomics to Therapeutics 2026

It was a pleasure for Genique Lifesciences to be part of an insightful session at Tata Memorial Hospital (TMH), featuring Aaron Lin from @ElemBio Element Biosciences

The session focused on the evolving role of sequencing in research and precision oncology. Aaron shared valuable insights into Element Biosciences’ sequencing technologies and their applications in advancing genomic workflows.

As the distributor of Element Biosciences in India, Genique Lifesciences is committed to supporting the research and clinical genomics community with access to innovative sequencing solutions.

Our sincere thanks to Aaron Lin, Dr. Omshree Shetty, and the TMH team for the opportunity and for an engaging exchange of knowledge and ideas.

#GeniqueLifeSciences #ElementBiosciences #Genomics #PrecisionOncology

[Genique Lifesciences @GeniqueLS]

One question worth sitting with as you read: if the matched therapy is out of reach, should the finding still count as actionable?

#IndiaGenomicsLandscape #PrecisionOncology #Genomics

[Genique Lifesciences @GeniqueLS]

A positive test result is not the same as a treatment - it holds the whole problem in a single sentence.

A tumor gets profiled, an actionable mutation turns up with a matching targeted therapy, and hope enters the room.

Then the data complicate things. For advanced cancer in India, the gap between being profiled and still being on the matched drug months later is far wider than most people assume, and the reason sits downstream of the lab entirely: whether the drug is available, whether the patient can afford it, whether anyone will pay for it.

Sequencing is necessary, and nowhere near sufficient. What the other half of the job looks like, and where we think a genomic report's responsibility really ends, is in the slides below.

[Genique Lifesciences @GeniqueLS]

One question worth sitting with as you read: if the matched therapy is out of reach, should the finding still count as actionable?

#IndiaGenomicsLandscape #PrecisionOncology #Genomics

[Element Biosciences @ElemBio]

Accuracy has a new baseline.

Spend less time second-guessing results and more time acting on them. With lower error rates and higher throughput, VITARI™ helps you find what matters—right from your benchtop.

If this is what VITARI looks like now, pay attention to what's next. Stay in the know: https://t.co/daqWyryNHe.

#VITARI #Seqeuncing

[Genique Lifesciences @GeniqueLS]

How not to make these three mistakes? The instrument is the easy part. It is rarely the part that decides whether the lab works.

[Genique Lifesciences @GeniqueLS]

The sequencer usually arrives before the entire workflow is up and running.

The pipeline is still under validation. The variant set is yet to be curated. Everyone is learning the new technique.

Finally, the machine runs; the clinician waits for the report.

Validation gets treated as paperwork after go-live. Coverage thresholds, reference materials, an SOP trail.

Designed in, they are cheap. Retrofitted onto live clinical samples, they are not, and the cost lands on the lab.

Then the cost model. A flow cell is cheap per run at full load. Per reportable sample it is another number, because real volumes arrive in ones and twos, runs go out half full, and reagents wait in a cold chain.

#Genomics #Sequencing 1/2